National survey of live attenuated vaccines for patients using immunosuppressive or biological agents

National survey of live attenuated vaccines for patients using immunosuppressive or biological agents - National survey of live vaccines

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029176

Enrollment

500

Registered

2017-09-19

Start date

2017-09-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients using immunosuppressive or biological agents

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of either of renal, rheumatic, liver or digestive disease or organ transplant recipients using immunosuppressive or biological agents who received live-attenuated vaccines.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
As this study is observational study, we did not decide the primary outcomes.	—

Countries

Japan

Contacts

Public ContactKoichi Kamei

National Center for Child Health and Development Division of Nephrology and Rheumatology

kamei-k@ncchd.go.jp03-5494-7128

Outcome results